ADVANCED LUNG NON-SMALL CELL CARCINOMA
Clinical trials for ADVANCED LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost lung cancer treatment
Disease control Not yet recruitingThis study tests whether adding a cancer vaccine (CIMAVAX-EGF) to standard targeted pills (sotorasib or adagrasib) can help people with advanced KRAS G12C-mutated lung cancer live longer without their disease getting worse. About 29 adults with stage III or IV non-small cell lung…
Matched conditions: ADVANCED LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New hope for advanced lung cancer patients: drug combo aims to reawaken immune system
Disease control Not yet recruitingThis study tests a new two-drug combination (SX-682 and atezolizumab) for people with advanced non-small cell lung cancer whose cancer continued to grow after chemotherapy and immunotherapy. The goal is to see if the combination can shrink tumors or slow the disease. About 32 adu…
Matched conditions: ADVANCED LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 08:19 UTC